Bonk (BONK) is moving in a downward direction with a notable decrement in its price due to high volatile conditions in the crypto market. The BONK price has declinedBonk (BONK) is moving in a downward direction with a notable decrement in its price due to high volatile conditions in the crypto market. The BONK price has declined

Bonk (BONK) Price Prediction: Is a Rally Toward $0.00001250 on the Horizon?

2025/12/12 18:00
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
  • BONK continues sliding downward as increased market volatility pressures the token near key support zones.
  • A breakdown below the $0.00001 level signals sustained bearish momentum with potential downside to $0.00000350.
  • A decisive move above $0.00001250 could trigger strong bullish momentum, opening the door for significant upside gains.

Bonk (BONK) is moving in a downward direction with a notable decrement in its price due to high volatile conditions in the crypto market. The BONK price has declined by 7.42% over the last 24 hours and 4.14% over the last week.

At the time of writing, BONK is trading at $0.000009328, supported by a 24-hour trading volume of $110.99 million, marking a dip of 18.07% over the last 24 hours. Moreover, its market capitalization remains solid at $771.38 million, placing the token among well-known crypto coins.

Source: CoinMarketCap

Also Read: BONK’s Strategic Fee Shift to Accelerate BNKK’s DAT Purchases

The BONK chart shows significant volatility between roughly 0.00001 and 0.00005 USD. Bollinger Bands highlight periods of expansion and contraction, reflecting spikes in volatility followed by consolidation. Currently trading near the lower band, the asset appears to be at a relative support level, with historical resistance around 0.00003–0.00004 limiting upward moves.

Source: TradingVIew

The RSI at 35.80 is nearing the oversold region, which may provide a countertrend move. However, it has been trending downward since mid-2025, forming lower highs and lower lows, which gives a bearish indication. A reversal in this region can be seen near the support line or a fall below 0.00001, while a declining Bollinger Bands line adds strength to a fall.

BONK Targets $0.00001250 Amid Market Volatility

Moreover, the crypto analyst, Crypto Patel, highlighted that BONK has just broken down a key support point around $0.00001 and has been aggressively retesting it since. Market players are closely monitoring this as a key area; holding it or falling below it would potentially set this token’s near-term trend. A breakdown could lead to sharp falls in the weeks ahead.

The critical zone remains between 0.000010 and 0.00001125; below this zone, it implies bearish momentum. On this note, a potential retracement may occur towards 0.00000450 – 0.00000350, which will be a prominent area for accumulating wealth. Silence in accumulation usually precedes a fundamental bull move and a sudden breakout.

Source: Crypto Patel

On a positive note, a clean breakout above $0.00001250 may unleash a super bull run for BONK, which would attract new buying volumes. The prospects of 200-400% gains make this a major target area for traders looking for high momentum and exponential expansion. These critical areas must be closely watched for smart entry and exit points.

Also Read: BONK on the Rise: Analysts Eye $0.0000217 Breakout

Market Opportunity
Bonk Logo
Bonk Price(BONK)
$0.000005821
$0.000005821$0.000005821
-0.37%
USD
Bonk (BONK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09